Das Stuttgarter Unternehmensmodell in der Theorie - Wissen im Kontext der Wandlungsfähigkeit (2009)
Berger, S., Mangold, C., Meyer, S., Westkämper, E., Zahn, E.
Ongoing genome reduction in Mycobacterium ulcerans (2007)
Rondini, S., Käser, M., Stinear, T., Tessier, M., Mangold, C., Dernick, G., ...
Elucidation of the transmission, epidemiology, and evolution of Mycobacterium ulcerans, the causative agent of Buruli ulcer, is hampered by the striking lack of genetic diversity of this emerging...
Knowledge Management in Assembly (2006)
Berger, S., Mangold, C., Meyer, S., Westkämper, E.
Turbulent business environments force enterprises to ever faster answers and adaptions in order to secure their competitive ability. Especially mass customization can be seen as one driver for...
Knowledge management in assembly (2005)
Berger, S., Mangold, C., Meyer, S., Westkämper, E.
Turbulent business environments force enterprises to ever faster answers and adaptions in order to secure their competitive ability. Especially mass customization can be seen as one driver for...
Berger, S., Mangold, C., Meyer, S.
Turbulent business environments force enterprises to ever faster answer and adaptions in order to secure their competitive ability. Mutability and responseability as crucial success factors are based...
Wissensmanagement für die wandlungsfähige Montage: Wissen als Antwort auf turbulente Zeiten (2004)
Berger, S., Mangold, C., Meyer, S.
Turbulent business environments force enterprises to develop answers and adaptions quickly. Mutability and responseability as crucial factors for success are based upon knowledge that has to be...
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma (1994)
Moore, D. F., Pazdur, R., Abbruzzese, J. L., Ajani, J. A., Dubovsky, D. W., Wade, J. L., ...
Background The methotrexate analogue 10-ethyl-10-deazaaminopterin (10-EdAM, or edatrexate) has shown antitumor activity in preclinical testing and clinical studies of patients with breast, lung and...